Cargando…
Modelling chemotherapy effects on granulopoiesis
BACKGROUND: Although the growth-factor G-CSF is widely used to prevent granulotoxic side effects of cytotoxic chemotherapies, its optimal use is still unknown since treatment outcome depends on many parameters such as dosing and timing of chemotherapies, pharmaceutical derivative of G-CSF used and i...
Autores principales: | Schirm, Sibylle, Engel, Christoph, Loeffler, Markus, Scholz, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302124/ https://www.ncbi.nlm.nih.gov/pubmed/25539928 http://dx.doi.org/10.1186/s12918-014-0138-7 |
Ejemplares similares
-
A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment
por: Schirm, Sibylle, et al.
Publicado: (2014) -
A Biomathematical Model of Human Erythropoiesis under Erythropoietin and Chemotherapy Administration
por: Schirm, Sibylle, et al.
Publicado: (2013) -
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy
por: Schirm, Sibylle, et al.
Publicado: (2017) -
Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans
por: Scholz, Markus, et al.
Publicado: (2012) -
Merging concepts - coupling an agent-based model of hematopoietic stem cells with an ODE model of granulopoiesis
por: Krinner, Axel, et al.
Publicado: (2013)